Trial Profile
Sitagliptin Study in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glipizide
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Merck & Co
- 07 Aug 2008 New trial record.